GRANDINI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 667
EU - Europa 394
AS - Asia 123
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.220
Nazione #
US - Stati Uniti d'America 666
GB - Regno Unito 114
SE - Svezia 77
DE - Germania 59
CN - Cina 55
IT - Italia 49
VN - Vietnam 25
IN - India 23
IE - Irlanda 20
TG - Togo 18
FR - Francia 16
RU - Federazione Russa 16
BE - Belgio 15
ZA - Sudafrica 10
EE - Estonia 9
UA - Ucraina 9
JO - Giordania 8
CI - Costa d'Avorio 5
BG - Bulgaria 4
IR - Iran 3
CH - Svizzera 2
HK - Hong Kong 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
FI - Finlandia 1
ID - Indonesia 1
JP - Giappone 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.220
Città #
Southend 108
Fairfield 80
Chandler 72
Ann Arbor 62
Ashburn 54
Cambridge 40
Seattle 40
Woodbridge 40
Houston 38
Wilmington 36
Princeton 26
Dong Ket 25
Dublin 20
Lomé 18
Nanjing 16
Brussels 15
Bremen 12
Westminster 12
Padova 10
Berlin 9
Jinan 9
Amman 8
Bologna 8
Florence 8
Turin 8
Dolo 7
Saint Petersburg 7
Beijing 6
San Diego 6
Abidjan 5
Boardman 5
Changsha 4
Dearborn 4
Jiaxing 4
Nanchang 4
New York 4
Sofia 4
Hebei 3
Los Angeles 3
Norwalk 3
Redmond 3
Abeokuta 2
Bühl 2
Lanzhou 2
Monmouth Junction 2
Piandimeleto 2
Redwood City 2
San Francisco 2
Stockholm 2
Tianjin 2
Aachen 1
Amsterdam 1
Ardabil 1
Bryanston 1
Buffalo 1
Central 1
Central District 1
Chengdu 1
Costa Mesa 1
Des Moines 1
Dhaka 1
Falls Church 1
Frankfurt am Main 1
Helsinki 1
Istanbul 1
Jacksonville 1
Medford 1
Moscow 1
Mountain View 1
Mülheim 1
Olalla 1
Orange 1
Paris 1
Phoenix 1
Plauen 1
Rome 1
Shenyang 1
Singapore 1
Sukkur 1
Surabaya 1
Taizhou 1
Tappahannock 1
Tokyo 1
Toronto 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 901
Nome #
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 124
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 122
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 115
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 112
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 109
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 104
Stem cells for end stage liver disease: How far have we got? 98
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 97
null 92
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 88
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. 84
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 48
Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. 46
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY 4
Totale 1.243
Categoria #
all - tutte 2.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 10 6 20
2019/2020366 46 11 1 21 35 39 48 54 53 27 7 24
2020/2021146 31 20 7 1 4 1 5 11 13 4 9 40
2021/2022254 11 14 25 14 19 13 7 14 7 29 56 45
2022/2023325 25 53 17 52 20 22 7 15 58 15 26 15
2023/202460 7 13 4 6 5 13 3 5 1 3 0 0
Totale 1.243